Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07266506 · ClinicalTrials.gov registry record · NA
Development of an Eating Behavior Risk Score
A NA study, sponsored by Penn State University.
- Not yet
- Registry status
- NA
- Development phase
- 420
- Enrollment target
NCT07266506: Clinical Trial NA study, sponsored by Penn State University.
NCT07266506 is a NA study that has not yet begun recruiting, run by Penn State University. The registered enrollment target is 420 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07266506, a NA study, has not yet begun recruiting, sponsored by Penn State University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 420 participants
- Enrollment target
Study Summary
This study will explore how children's eating behaviors are connected to brain activity and body fat levels. Researchers are especially interested in a behavior pattern called the PACE phenotype, which includes how much children eat when offered large portions, how quickly they eat, their appetite traits, and their ability to control eating. The goal is to better understand why some children are more likely to gain weight than others. The study will include children between the ages of 7 and 9 and will follow them for one year. Researchers will use brain scans, lab-based meal observations, and questionnaires to study how children respond to food and how their eating patterns relate to body fat at the start of the study and one year later. The study will also look at how family background, parenting, and other factors might protect some children from gaining excess weight even if they show risky eating behaviors. Results may help identify which children are most at risk for obesity and guide future strategies for prevention.
Primary Outcome
Functional magnetic resonance imaging (fMRI) will be used to measure brain activation in response to images of palatable, energy-dense food portions of varying sizes. Activation will be assessed in brain regions involved in visceral interoception (e.g., insula, cerebellum) and self-regulation (e.g., dorsolateral prefrontal cortex). These neural responses will be correlated with children's PACE phenotype scores to explore neurobiological underpinnings of eating behaviors.
Interventions
- BEHAVIORAL Assessment of PACE Eating Phenotype and Related Behavioral and Neurobiological Measures
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 420 participants |
| Start Date | 2026-07-01 |
| Est. Completion | 2032-06-30 |
| Phase | NA |
What is known before NCT07266506 opens enrollment
NCT07266506 is an interventional study that assigns participants to a tested intervention. The registered 420 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower).
The record links to 0 conditions, and to 1 intervention - of which Assessment of PACE Eating Phenotype and Related Behavioral and Neurobiological Measures is the first listed.
NCT07266506 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07266506 about?
NCT07266506 is a clinical study titled "Development of an Eating Behavior Risk Score". This study will explore how children's eating behaviors are connected to brain activity and body fat levels. Researchers are especially interested in a behavior pattern called the PACE phenotype, which includes how much children eat when offered large portions, how quickly they eat, their appetite t...
What is the current status of trial NCT07266506?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 420 participants. The study started on 2026-07-01. Estimated completion is 2032-06-30.
What interventions are being tested in trial NCT07266506?
The interventions under investigation include: Assessment of PACE Eating Phenotype and Related Behavioral and Neurobiological Measures (BEHAVIORAL).
Who is sponsoring clinical trial NCT07266506?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07266506's enrollment target sits among peer trials
420 239th of 2000 higher than 1,761 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01790152 · 420 participants
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- NCT02701244 · 420 participants
A Registry Study of Breast Microseed Treatment
- NCT02966665 · 420 participants · Phase 1
: Vascular Function in Health and Disease
- NCT04149743 · 420 participants · NA
HEMOTAG® Assessment for Short-term Outcomes of Heart Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI